» Articles » PMID: 37657519

A Multipathway Phosphopeptide Standard for Rapid Phosphoproteomics Assay Development

Abstract

Recent advances in methodology have made phosphopeptide analysis a tractable problem for many proteomics researchers. There are now a wide variety of robust and accessible enrichment strategies to generate phosphoproteomes while free or inexpensive software tools for quantitation and site localization have simplified phosphoproteome analysis workflow tremendously. As a research group under the Association for Biomolecular Resource Facilities umbrella, the Proteomics Standards Research Group has worked to develop a multipathway phosphopeptide standard based on a mixture of heavy-labeled phosphopeptides designed to enable researchers to rapidly develop assays. This mixture contains 131 mass spectrometry vetted phosphopeptides specifically chosen to cover as many known biologically interesting phosphosites as possible from seven different signaling networks: AMPK signaling, death and apoptosis signaling, ErbB signaling, insulin/insulin-like growth factor-1 signaling, mTOR signaling, PI3K/AKT signaling, and stress (p38/SAPK/JNK) signaling. Here, we describe a characterization of this mixture spiked into a HeLa tryptic digest stimulated with both epidermal growth factor and insulin-like growth factor-1 to activate the MAPK and PI3K/AKT/mTOR pathways. We further demonstrate a comparison of phosphoproteomic profiling of HeLa performed independently in five labs using this phosphopeptide mixture with data-independent acquisition. Despite different experimental and instrumentation processes, we found that labs could produce reproducible, harmonized datasets by reporting measurements as ratios to the standard, while intensity measurements showed lower consistency between labs even after normalization. Our results suggest that widely available, biologically relevant phosphopeptide standards can act as a quantitative "yardstick" across laboratories and sample preparations enabling experimental designs larger than a single laboratory can perform. Raw data files are publicly available in the MassIVE dataset MSV000090564.

Citing Articles

A framework for quality control in quantitative proteomics.

Tsantilas K, Merrihew G, Robbins J, Johnson R, Park J, Plubell D bioRxiv. 2024; .

PMID: 38645098 PMC: 11030400. DOI: 10.1101/2024.04.12.589318.

References
1.
Ferguson F, Gray N . Kinase inhibitors: the road ahead. Nat Rev Drug Discov. 2018; 17(5):353-377. DOI: 10.1038/nrd.2018.21. View

2.
Bekker-Jensen D, Bernhardt O, Hogrebe A, Martinez-Val A, Verbeke L, Gandhi T . Rapid and site-specific deep phosphoproteome profiling by data-independent acquisition without the need for spectral libraries. Nat Commun. 2020; 11(1):787. PMC: 7005859. DOI: 10.1038/s41467-020-14609-1. View

3.
Stensballe A, Andersen S, Jensen O . Characterization of phosphoproteins from electrophoretic gels by nanoscale Fe(III) affinity chromatography with off-line mass spectrometry analysis. Proteomics. 2001; 1(2):207-22. DOI: 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.0.CO;2-3. View

4.
Pino L, Just S, MacCoss M, Searle B . Acquiring and Analyzing Data Independent Acquisition Proteomics Experiments without Spectrum Libraries. Mol Cell Proteomics. 2020; 19(7):1088-1103. PMC: 7338082. DOI: 10.1074/mcp.P119.001913. View

5.
Escher C, Reiter L, MacLean B, Ossola R, Herzog F, Chilton J . Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics. 2012; 12(8):1111-21. PMC: 3918884. DOI: 10.1002/pmic.201100463. View